Product image of Metforalmille (Metformin Hydrochloride) supplied by GNH India

Metforalmille

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metforalmille (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metforalmille, is a biguanide presented as an oral tablet for oral use. It helps lower elevated blood glucose by improving insulin sensitivity and reducing hepatic glucose production in adults diagnosed with type 2 diabetes mellitus and safety.

GNH India supplies Metforalmille as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards and a focus on quality assurance for antidiabetic medicines through reliable logistics, ensuring timely delivery.

Manufacturer / TM Owner

Laboratori Guidotti S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metforalmille (metformin hydrochloride) is used in the management of disorders related to glucose metabolism, primarily type 2 diabetes mellitus.

  • Type 2 diabetes mellitus: improves overall glycemic control and lowers HbA1c levels.
  • Impaired glucose tolerance: reduces the risk of progression to overt diabetes.
  • Polycystic ovary syndrome: enhances insulin sensitivity and may help restore regular ovulation.

How It Works

  • Metformin hydrochloride acts primarily by inhibiting hepatic gluconeogenesis, thereby decreasing hepatic glucose output. It also modestly reduces intestinal glucose absorption and increases peripheral tissue uptake of glucose through activation of AMP‑activated protein kinase, which improves insulin sensitivity without stimulating insulin secretion.

Side Effects

Metforalmille may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
  • Diarrhea: loose stools that may be mild to moderate.
  • Metallic taste: a transient metallic sensation in the mouth.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: a rare but life‑threatening accumulation of lactate.
  • Severe hypoglycemia: usually when combined with other glucose‑lowering agents.
  • Hepatic dysfunction: signs of liver injury.
  • Allergic reactions: rash, pruritus, or angioedema.
  • Metabolic acidosis: especially in patients with renal impairment.

Precautions & Warnings

Before initiating Metforalmille, clinicians should consider several safety factors.

  • Renal function: assess creatinine clearance and avoid use in severe renal impairment.
  • Lactic acidosis risk: contraindicated in patients with significant heart failure, hepatic disease, or hypoxia.
  • Alcohol consumption: limit intake to reduce the risk of lactic acidosis.
  • Vitamin B12 monitoring: periodic assessment recommended for long‑term therapy.
  • Pregnancy and lactation: use only if potential benefits justify potential risks.
  • Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Avoid Interactions

Metforalmille can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
  • Cimetidine: can raise metformin plasma concentrations.
  • Alcohol: synergistic effect on lactate accumulation.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask symptoms of hypoglycemia.
  • ACE inhibitors or ARBs: monitor renal function and electrolytes.
  • Thiazide diuretics: may enhance hypoglycemic effect of metformin.

Frequently Asked Questions

Metforalmille contains metformin hydrochloride and is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus. It works by lowering hepatic glucose production and enhancing insulin sensitivity, helping patients achieve target glycemic levels.

Metformin primarily inhibits gluconeogenesis in the liver, reducing the amount of glucose released into the bloodstream. It also modestly decreases intestinal glucose absorption and activates AMP‑activated protein kinase, which increases peripheral uptake of glucose and improves insulin sensitivity.

The dosage of Metforalmille is individualized. A qualified prescriber determines the appropriate dose based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescribing information provided by their healthcare professional.

Safety data for metformin in pregnancy are limited, and the pregnancy category is unknown. It should only be used during pregnancy or lactation if the potential benefits outweigh the risks, and this decision must be made by the treating physician.

To request Metforalmille, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metforalmille (metformin) belongs to the biguanide class, which differs from sulfonylureas that stimulate insulin secretion. Metformin does not cause weight gain and has a lower risk of hypoglycemia when used alone, making it a first‑line option for many patients with type 2 diabetes.

Metforalmille should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the packaging.

Metforalmille is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are determined by the prescribing clinician.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, heart failure, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metforalmille is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving iodinated contrast studies without adequate renal monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT